Pharmacodynamic study of antiangiogenic therapy in patients with renal cell carcinoma.
Gayathri Anandappa, Tim Eisen, Brandon Whitcher(Royal Marsden NHS Foundation Trust), Donald Richards(The US Oncology Network), Louise Cookson, W. M. F. Lee, Alison Backen(Cancer Research UK), Caroline Dive(University of Manchester), Rushaine Smith, Kate Fife(Addenbrooke's Hospital), Andrew Shaw, Amy L. Jonson, Yong-Kil Hong, Elisa Sala, Andrew B. Gill, D. Jodrell, Nicholas J. Bird(Cambridge University Hospitals NHS Foundation Trust), Andrew N. Priest, H.K. Cheow, Tim D. Fryer(University of Cambridge)
Cited by 0
Related Papers
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
An Introduction to Wavelets and Other Filtering Methods in Finance and Economics
|Elsevier eBooks|2002|1.1k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642